International Collaboration

Collaboration with the World Dementia Council (WDC)

The WDC is an independent charity that is based in London and operates internationally. The Council comprises 24 members from all sectors of society around the globe, including HGPI Chairman Kiyoshi Kurokawa. The Council aims to improve dementia countermeasures through international advocacy, international leadership, and the building of global networks.

In addition, the WDC, together with HGPI, has conducted research on the current situation of dementia and the problems presented by dementia prevention as a partner in the “Research Project on the Construction and Use of a Model for International Public-Private Partnerships (PPP) in Dementia Research” joint research project which was conducted by HGPI with the support of AMED. It also gave its recommendations and suggestions for Japan.

Based on these achievements, the 12th meeting of the WDC was held in March 2018, co-sponsored by HGPI and WDC. During that meeting, members discussed which actions that need to be taken to accelerate progress and agreed to focus on four areas: awareness, research, care, and risk reduction. On the sidelines of the WDC12 meeting, a Japan-UK Dementia Conference was held. It was organized by HGPI together with WDC and media organizations from Japan and the United Kingdom (Nikkei and the Financial Times). During this conference, guests shared knowledge about dementia from Japan and the United Kingdom and had an in-depth discussion on how to create and make use of international Public-Private Partnerships (PPPs).

Research Proposal on Post Diagnosis Support in Scotland

Early diagnosis and early response are considered important in dementia measures. Although this concept is described with various expressions, the situation is same for every country. However, it is not rare for the patients to become isolated and have their condition worsen due to the lack of appropriate post diagnosis support (PDS). Therefore, a research proposal was created with suggestions for Japan based on the policy in Scotland, which is the country with the most highly-developed PDS.

*This investigation was held with the support from the Global Health Innovation Policy Program (GHIPP) by the National Graduate Institute for Policy Studies.